Quan Bao

721 total citations · 1 hit paper
36 papers, 469 citations indexed

About

Quan Bao is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Quan Bao has authored 36 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 22 papers in Hepatology and 18 papers in Surgery. Recurrent topics in Quan Bao's work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Colorectal Cancer Treatments and Studies (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers). Quan Bao is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Colorectal Cancer Treatments and Studies (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers). Quan Bao collaborates with scholars based in China, Ethiopia and Italy. Quan Bao's co-authors include Baocai Xing, Kun Wang, Kemin Jin, Yi Sun, Xiaoluan Yan, Renjie Yang, Hongwei Wang, Xu Zhu, Hongwei Wang and Guang Cao and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and Annals of Surgical Oncology.

In The Last Decade

Quan Bao

33 papers receiving 468 citations

Hit Papers

Sorafenib Plus Hepatic Arterial Infusion Chemotherapy ver... 2022 2026 2023 2024 2022 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial
    2022 101 citations Xu Zhu, Guang Cao et al. Radiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Quan Bao China 10 284 201 161 92 87 36 469
Yangxun Pan China 15 243 0.9× 161 0.8× 149 0.9× 46 0.5× 108 1.2× 55 492
Yizhen Fu China 13 227 0.8× 112 0.6× 100 0.6× 72 0.8× 78 0.9× 38 384
Shinichi Shibasaki Japan 14 187 0.7× 178 0.9× 251 1.6× 50 0.5× 141 1.6× 37 487
Clive Stubbs United Kingdom 8 319 1.1× 173 0.9× 208 1.3× 146 1.6× 165 1.9× 17 558
Hiroaki Nagamatsu Japan 12 388 1.4× 79 0.4× 126 0.8× 88 1.0× 82 0.9× 32 517
Nafis Shafizadeh United States 14 275 1.0× 175 0.9× 299 1.9× 47 0.5× 76 0.9× 20 625
Yi-fa Chen China 13 244 0.9× 155 0.8× 202 1.3× 62 0.7× 60 0.7× 18 603
C. Gog Germany 10 181 0.6× 183 0.9× 90 0.6× 69 0.8× 69 0.8× 28 341
L.-T. Chen Taiwan 10 254 0.9× 170 0.8× 132 0.8× 63 0.7× 115 1.3× 19 511

Countries citing papers authored by Quan Bao

Since Specialization
Citations

This map shows the geographic impact of Quan Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quan Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quan Bao more than expected).

Fields of papers citing papers by Quan Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quan Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quan Bao. The network helps show where Quan Bao may publish in the future.

Co-authorship network of co-authors of Quan Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Quan Bao. A scholar is included among the top collaborators of Quan Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quan Bao. Quan Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lijun, Quan Bao, Hongwei Wang, et al.. (2025). Predictive Factors for Chemotherapy Response in Colorectal Liver Metastasis: A Retrospective Study Utilizing Next-Generation Sequencing. Annals of Surgical Oncology. 32(8). 6067–6079.
2.
Bao, Quan, et al.. (2024). Comparing baseline VAF in circulating tumor DNA and tumor tissues predicting prognosis of patients with colorectal cancer liver metastases after curative resection. Clinics and Research in Hepatology and Gastroenterology. 48(9). 102464–102464. 2 indexed citations
3.
Bao, Quan, Tingting Zhao, Longfei Huang, et al.. (2024). Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases. Hepatology International. 18(3). 1029–1039. 4 indexed citations
4.
5.
Yan, Xiaoluan, Hongwei Wang, Kemin Jin, et al.. (2023). Five‐year survival post hepatectomy for colorectal liver metastases in a real‐world Chinese cohort: Recurrence patterns and prediction for potential cure. Cancer Medicine. 12(8). 9559–9569. 14 indexed citations
6.
Wang, Kun, Quan Bao, Hongwei Wang, et al.. (2023). Efficacy and safety of IBI110 in combination with sintilimab and lenvatinib in first-line of advanced hepatocellular carcinoma: Preliminary results from a phase Ib study.. Journal of Clinical Oncology. 41(16_suppl). 2577–2577. 1 indexed citations
7.
Jin, Kemin, et al.. (2023). Recurrence Prediction by Circulating Tumor DNA in the Patient with Colorectal Liver Metastases After Hepatectomy: A Prospective Biomarker Study. Annals of Surgical Oncology. 30(8). 4916–4926. 9 indexed citations
8.
Wang, Yanyan, Kun Wang, Quan Bao, et al.. (2023). Combined ablation and resection (CARe) for resectable colorectal cancer liver Metastases-A propensity score matching study. European Journal of Surgical Oncology. 49(9). 106931–106931. 6 indexed citations
9.
Zhu, Xu, Guang Cao, Wenqing Li, et al.. (2022). Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial. Radiology. 303(2). 455–464. 101 indexed citations breakdown →
10.
Bao, Xuanwen, Kun Wang, Ming Liu, et al.. (2022). Characterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic Value. Frontiers in Cell and Developmental Biology. 9. 760618–760618. 31 indexed citations
11.
Capelli, Giulia, Giulia Lorenzoni, Quan Bao, et al.. (2021). Validation of a Nomogram to Predict Long Term Outcomes After Curative Surgery for Gastric Cancer in an Italian Cohort of Patients. Journal of Visceral Surgery. 159(6). 471–479. 2 indexed citations
12.
Yan, Xiaoluan, Kun Wang, Quan Bao, et al.. (2021). En bloc right hemicolectomy with pancreatoduodenectomy for right-sided colon cancer invading duodenum. BMC Surgery. 21(1). 302–302. 6 indexed citations
13.
Wang, Hongwei, Xiaoluan Yan, Lijun Wang, et al.. (2021). Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastases. Journal of Translational Medicine. 19(1). 313–313. 8 indexed citations
14.
15.
Wang, Kun, Hongwei Wang, Kemin Jin, et al.. (2021). Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases. Frontiers in Oncology. 11. 643375–643375. 3 indexed citations
16.
Jin, Kemin, Kun Wang, Quan Bao, Hongwei Wang, & Baocai Xing. (2020). Liver resection for colorectal liver-limited metastases in elderly patients: a propensity score matching analysis. World Journal of Surgical Oncology. 18(1). 275–275. 9 indexed citations
17.
Liu, Wei, Kun Wang, Quan Bao, Yi Sun, & Baocai Xing. (2016). Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma. World Journal of Surgical Oncology. 14(1). 62–62. 38 indexed citations
18.
Jin, Kemin, Xiaoluan Yan, Kun Wang, et al.. (2015). [Prognostic significance of clinical risk score system after resection of hepatic metastases from colorectal cancer].. PubMed. 37(12). 913–6. 1 indexed citations
19.
Bao, Quan, et al.. (2007). Protein Expression of Osteopontin in Tumor Tissues Is an Independent Prognostic Indicator in Gastric Cancer. Oncology. 72(1-2). 89–96. 32 indexed citations
20.
Bao, Quan, et al.. (2006). Expression of Cdx2 is associated with clinicopathologic features and prognosis of gastric carcinoma. Chinese Journal of Cancer Research. 18(2). 105–110. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yangxun Pan Breakdown of academic impact, for papers by Yizhen Fu Breakdown of academic impact, for papers by Shinichi Shibasaki Breakdown of academic impact, for papers by Clive Stubbs Breakdown of academic impact, for papers by Hiroaki Nagamatsu Breakdown of academic impact, for papers by Nafis Shafizadeh Breakdown of academic impact, for papers by Yi-fa Chen Breakdown of academic impact, for papers by C. Gog Breakdown of academic impact, for papers by L.-T. Chen
Rankless by CCL
2026